Full article available to subscribers
Clinical—A 10-year-old girl presented to the Emergency Department with a 2-week history of pain and swelling of the thumb. There was no history of trauma nor signs of sepsis. Plain radiographs revealed an aggressive lesion in the proximal phalanx of the thumb (Figure 1). MRI showed the lesion to have breached the cortex, but confirmed sparing of the adjacent epiphysis (Figure 2 A and B).What is the diagnosis?Answer and DiscussionFigure 1. Oblique view of the left thumb showing a mixed sclerotic and lytic lesion in the proximal phalanx, with associated periosteal new bone formation Figures 2A & 2B: Coronal MR images of the left thumb (A) STIR, and (B) T1-weighted(A) (B) Note: There is a destructive lesion in the proximal phalanx, which has breached the cortex and elicited periosteal new bone formation (respectively indicated by the opposing arrows on the STIR image. Cortical destruction is signalled by the uppermost arrow on the T1-weighted image). The lesion is heterogeneous and there is associated marrow oedema. The adjacent soft tissue involvement is minimal. The proximal phalangeal epiphysis remains normal (more inferiorly placed arrows on both STIR and T1-weighted images).
1. Reinus WR, Gilula LA, Shirley SK, et al. Radiographic appearances of Ewing sarcoma of the hands and feet: report from the Intergroup Ewing Sarcoma Study. Am J Roentgenol. 1985;144:331-6 2. Escobedo EM, Bjorkengren AG, Moore SG. Ewings sarcoma of the hand. Am J Roentgenol. 1992;159:101-2.
Sign in to view your account and access
the latest publications by the NZMJ.
Don't have an account?
Let's get started with creating an account.
Already have an account?
Become a member to enjoy unlimited digital access and support the ongoing publication of the New Zealand Medical Journal.
The New Zealand Medical Journal is fully available to individual subscribers and does not incur a subscription fee. This applies to both New Zealand and international subscribers. Institutions are encouraged to subscribe. The value of institutional subscriptions is essential to the NZMJ, as supporting a reputable medical journal demonstrates an institution’s commitment to academic excellence and professional development. By continuing to pay for a subscription, institutions signal their support for valuable medical research and contribute to the journal's continued success.
Please email us at nzmj@pmagroup.co.nz